Reimagining neurological treatments: A brain on a chip
The Evolution of Drug Testing: Beyond Animal Models As the global population continues to struggle with the increasing prevalence of neurological and psychiatric disorders—impacting nearly 3.4 billion people worldwide—the traditional methods of drug development are proving insufficient. Despite their popularity, animal models, especially mice, have a mere 5% success rate in translating preclinical studies to … Read more